Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,666
archived clinical trials in
Hospital

CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients
A Phase 3 Trial of Calfactant for ALI in Pediatric Leukemia and HSCT Patients
Status: Enrolling
Updated:  2/15/2018
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients
A Phase 3 Trial of Calfactant for ALI in Pediatric Leukemia and HSCT Patients
Status: Enrolling
Updated: 2/15/2018
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients
A Phase 3 Trial of Calfactant for ALI in Pediatric Leukemia and HSCT Patients
Status: Enrolling
Updated:  2/15/2018
Riley Children's Hospital
mi
from
Indianapolis, IN
CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients
A Phase 3 Trial of Calfactant for ALI in Pediatric Leukemia and HSCT Patients
Status: Enrolling
Updated: 2/15/2018
Riley Children's Hospital
mi
from
Indianapolis, IN
Click here to add this to my saved trials
CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients
A Phase 3 Trial of Calfactant for ALI in Pediatric Leukemia and HSCT Patients
Status: Enrolling
Updated:  2/15/2018
Hackensack University Medical Center
mi
from
Hackensack, NJ
CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients
A Phase 3 Trial of Calfactant for ALI in Pediatric Leukemia and HSCT Patients
Status: Enrolling
Updated: 2/15/2018
Hackensack University Medical Center
mi
from
Hackensack, NJ
Click here to add this to my saved trials
CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients
A Phase 3 Trial of Calfactant for ALI in Pediatric Leukemia and HSCT Patients
Status: Enrolling
Updated:  2/15/2018
Maria Fareri Childrens Hospital
mi
from
Valhalla, NY
CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients
A Phase 3 Trial of Calfactant for ALI in Pediatric Leukemia and HSCT Patients
Status: Enrolling
Updated: 2/15/2018
Maria Fareri Childrens Hospital
mi
from
Valhalla, NY
Click here to add this to my saved trials
CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients
A Phase 3 Trial of Calfactant for ALI in Pediatric Leukemia and HSCT Patients
Status: Enrolling
Updated:  2/15/2018
Rainbow Babies Hospital
mi
from
Cleveland, OH
CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients
A Phase 3 Trial of Calfactant for ALI in Pediatric Leukemia and HSCT Patients
Status: Enrolling
Updated: 2/15/2018
Rainbow Babies Hospital
mi
from
Cleveland, OH
Click here to add this to my saved trials
CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients
A Phase 3 Trial of Calfactant for ALI in Pediatric Leukemia and HSCT Patients
Status: Enrolling
Updated:  2/15/2018
Nationwide Children's Hospital
mi
from
Columbus, OH
CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients
A Phase 3 Trial of Calfactant for ALI in Pediatric Leukemia and HSCT Patients
Status: Enrolling
Updated: 2/15/2018
Nationwide Children's Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients
A Phase 3 Trial of Calfactant for ALI in Pediatric Leukemia and HSCT Patients
Status: Enrolling
Updated:  2/15/2018
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients
A Phase 3 Trial of Calfactant for ALI in Pediatric Leukemia and HSCT Patients
Status: Enrolling
Updated: 2/15/2018
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients
A Phase 3 Trial of Calfactant for ALI in Pediatric Leukemia and HSCT Patients
Status: Enrolling
Updated:  2/15/2018
St. Jude Children's Research Hospital
mi
from
Memphis, TN
CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients
A Phase 3 Trial of Calfactant for ALI in Pediatric Leukemia and HSCT Patients
Status: Enrolling
Updated: 2/15/2018
St. Jude Children's Research Hospital
mi
from
Memphis, TN
Click here to add this to my saved trials
CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients
A Phase 3 Trial of Calfactant for ALI in Pediatric Leukemia and HSCT Patients
Status: Enrolling
Updated:  2/15/2018
Texas Children's Hospital
mi
from
Houston, TX
CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients
A Phase 3 Trial of Calfactant for ALI in Pediatric Leukemia and HSCT Patients
Status: Enrolling
Updated: 2/15/2018
Texas Children's Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients
A Phase 3 Trial of Calfactant for ALI in Pediatric Leukemia and HSCT Patients
Status: Enrolling
Updated:  2/15/2018
Children's Hospital of Wisconsin
mi
from
Milwaukee, WI
CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients
A Phase 3 Trial of Calfactant for ALI in Pediatric Leukemia and HSCT Patients
Status: Enrolling
Updated: 2/15/2018
Children's Hospital of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients
A Phase 3 Trial of Calfactant for ALI in Pediatric Leukemia and HSCT Patients
Status: Enrolling
Updated:  2/15/2018
Weill Cornell Medical Center
mi
from
New York, NY
CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients
A Phase 3 Trial of Calfactant for ALI in Pediatric Leukemia and HSCT Patients
Status: Enrolling
Updated: 2/15/2018
Weill Cornell Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients
A Phase 3 Trial of Calfactant for ALI in Pediatric Leukemia and HSCT Patients
Status: Enrolling
Updated:  2/15/2018
Penn State College of Medicine, Penn State Milton S. Hershey Medical Center
mi
from
Hershey, PA
CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients
A Phase 3 Trial of Calfactant for ALI in Pediatric Leukemia and HSCT Patients
Status: Enrolling
Updated: 2/15/2018
Penn State College of Medicine, Penn State Milton S. Hershey Medical Center
mi
from
Hershey, PA
Click here to add this to my saved trials
CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients
A Phase 3 Trial of Calfactant for ALI in Pediatric Leukemia and HSCT Patients
Status: Enrolling
Updated:  2/15/2018
Children's Hospital of Pittsburgh
mi
from
Pittsburgh, PA
CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients
A Phase 3 Trial of Calfactant for ALI in Pediatric Leukemia and HSCT Patients
Status: Enrolling
Updated: 2/15/2018
Children's Hospital of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients
A Phase 3 Trial of Calfactant for ALI in Pediatric Leukemia and HSCT Patients
Status: Enrolling
Updated:  2/15/2018
Hospital Sainte Justine
mi
from
Montreal,
CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients
A Phase 3 Trial of Calfactant for ALI in Pediatric Leukemia and HSCT Patients
Status: Enrolling
Updated: 2/15/2018
Hospital Sainte Justine
mi
from
Montreal,
Click here to add this to my saved trials
CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients
A Phase 3 Trial of Calfactant for ALI in Pediatric Leukemia and HSCT Patients
Status: Enrolling
Updated:  2/15/2018
University of California at San Francisco
mi
from
San Francisco, CA
CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients
A Phase 3 Trial of Calfactant for ALI in Pediatric Leukemia and HSCT Patients
Status: Enrolling
Updated: 2/15/2018
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
A Gastrointestinal Quality of Life Study in Lung Transplant Recipients Converted From Mycophenolate Mofetil to Myfortic
Reduced Gastrointestinal Complaints and Improved Quality of Life in Lung Transplant Recipients Converted From Mycophenolate Mofetil (MMF) to Myfortic (Enteric-coated Mycophenolate Sodium, Ec-mps)
Status: Enrolling
Updated:  2/16/2018
Vanderbilt University Medical Center
mi
from
Nashville, TN
A Gastrointestinal Quality of Life Study in Lung Transplant Recipients Converted From Mycophenolate Mofetil to Myfortic
Reduced Gastrointestinal Complaints and Improved Quality of Life in Lung Transplant Recipients Converted From Mycophenolate Mofetil (MMF) to Myfortic (Enteric-coated Mycophenolate Sodium, Ec-mps)
Status: Enrolling
Updated: 2/16/2018
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
High-resolution Computed Tomography (HRCT) Evaluation of Airway Distensibility in Lung Transplant Recipients
High Resolution Computed Tomographic Evaluation of Airway Distensibility in Lung Transplant Recipients: A Pilot Study
Status: Enrolling
Updated:  2/19/2018
University of Texas Medical Branch
mi
from
Galveston, TX
High-resolution Computed Tomography (HRCT) Evaluation of Airway Distensibility in Lung Transplant Recipients
High Resolution Computed Tomographic Evaluation of Airway Distensibility in Lung Transplant Recipients: A Pilot Study
Status: Enrolling
Updated: 2/19/2018
University of Texas Medical Branch
mi
from
Galveston, TX
Click here to add this to my saved trials
Tranexamic Acid Mechanisms and Pharmacokinetics in Traumatic Injury
Tranexamic Acid Mechanisms and Pharmacokinetics in Traumatic Injury (TAMPITI TRIAL)
Status: Enrolling
Updated:  2/19/2018
Barnes Jewish Hospital
mi
from
Saint Louis, MO
Tranexamic Acid Mechanisms and Pharmacokinetics in Traumatic Injury
Tranexamic Acid Mechanisms and Pharmacokinetics in Traumatic Injury (TAMPITI TRIAL)
Status: Enrolling
Updated: 2/19/2018
Barnes Jewish Hospital
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Beta Blockade in Critical Injury
Beta-blockade Reduces Catabolism in Severely Injured Trauma Patients
Status: Enrolling
Updated:  2/20/2018
Denver Health Medical Center
mi
from
Denver, CO
Beta Blockade in Critical Injury
Beta-blockade Reduces Catabolism in Severely Injured Trauma Patients
Status: Enrolling
Updated: 2/20/2018
Denver Health Medical Center
mi
from
Denver, CO
Click here to add this to my saved trials
Improving Functions in MTBI Patients With Headache by rTMS
Improving Functions in MTBI Patients With Headache by rTMS
Status: Enrolling
Updated:  2/23/2018
VA San Diego Healthcare System, San Diego, CA
mi
from
San Diego, CA
Improving Functions in MTBI Patients With Headache by rTMS
Improving Functions in MTBI Patients With Headache by rTMS
Status: Enrolling
Updated: 2/23/2018
VA San Diego Healthcare System, San Diego, CA
mi
from
San Diego, CA
Click here to add this to my saved trials
A Study of Kytril (Granisetron) in the Prevention of Post-Operative Nausea and Vomiting (PONV) in Pediatric Subjects Undergoing Tonsillectomy or Adenotonsillectomy
A Randomized, Double-blind Study of 2 Dose Levels of Kytril on the Prevention of Post-operative Nausea and Vomiting in Pediatric Patients Undergoing Surgery With General Anesthesia
Status: Enrolling
Updated:  2/26/2018
Clinical Research Facility
mi
from
Fresno, CA
A Study of Kytril (Granisetron) in the Prevention of Post-Operative Nausea and Vomiting (PONV) in Pediatric Subjects Undergoing Tonsillectomy or Adenotonsillectomy
A Randomized, Double-blind Study of 2 Dose Levels of Kytril on the Prevention of Post-operative Nausea and Vomiting in Pediatric Patients Undergoing Surgery With General Anesthesia
Status: Enrolling
Updated: 2/26/2018
Clinical Research Facility
mi
from
Fresno, CA
Click here to add this to my saved trials
A Study of Kytril (Granisetron) in the Prevention of Post-Operative Nausea and Vomiting (PONV) in Pediatric Subjects Undergoing Tonsillectomy or Adenotonsillectomy
A Randomized, Double-blind Study of 2 Dose Levels of Kytril on the Prevention of Post-operative Nausea and Vomiting in Pediatric Patients Undergoing Surgery With General Anesthesia
Status: Enrolling
Updated:  2/26/2018
Clinical Research Facility
mi
from
Stanford, CA
A Study of Kytril (Granisetron) in the Prevention of Post-Operative Nausea and Vomiting (PONV) in Pediatric Subjects Undergoing Tonsillectomy or Adenotonsillectomy
A Randomized, Double-blind Study of 2 Dose Levels of Kytril on the Prevention of Post-operative Nausea and Vomiting in Pediatric Patients Undergoing Surgery With General Anesthesia
Status: Enrolling
Updated: 2/26/2018
Clinical Research Facility
mi
from
Stanford, CA
Click here to add this to my saved trials
A Study of Kytril (Granisetron) in the Prevention of Post-Operative Nausea and Vomiting (PONV) in Pediatric Subjects Undergoing Tonsillectomy or Adenotonsillectomy
A Randomized, Double-blind Study of 2 Dose Levels of Kytril on the Prevention of Post-operative Nausea and Vomiting in Pediatric Patients Undergoing Surgery With General Anesthesia
Status: Enrolling
Updated:  2/26/2018
Clinical Research Facility
mi
from
Hartford, CT
A Study of Kytril (Granisetron) in the Prevention of Post-Operative Nausea and Vomiting (PONV) in Pediatric Subjects Undergoing Tonsillectomy or Adenotonsillectomy
A Randomized, Double-blind Study of 2 Dose Levels of Kytril on the Prevention of Post-operative Nausea and Vomiting in Pediatric Patients Undergoing Surgery With General Anesthesia
Status: Enrolling
Updated: 2/26/2018
Clinical Research Facility
mi
from
Hartford, CT
Click here to add this to my saved trials
A Study of Kytril (Granisetron) in the Prevention of Post-Operative Nausea and Vomiting (PONV) in Pediatric Subjects Undergoing Tonsillectomy or Adenotonsillectomy
A Randomized, Double-blind Study of 2 Dose Levels of Kytril on the Prevention of Post-operative Nausea and Vomiting in Pediatric Patients Undergoing Surgery With General Anesthesia
Status: Enrolling
Updated:  2/26/2018
Clinical Research Facility
mi
from
Miami, FL
A Study of Kytril (Granisetron) in the Prevention of Post-Operative Nausea and Vomiting (PONV) in Pediatric Subjects Undergoing Tonsillectomy or Adenotonsillectomy
A Randomized, Double-blind Study of 2 Dose Levels of Kytril on the Prevention of Post-operative Nausea and Vomiting in Pediatric Patients Undergoing Surgery With General Anesthesia
Status: Enrolling
Updated: 2/26/2018
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
A Study of Kytril (Granisetron) in the Prevention of Post-Operative Nausea and Vomiting (PONV) in Pediatric Subjects Undergoing Tonsillectomy or Adenotonsillectomy
A Randomized, Double-blind Study of 2 Dose Levels of Kytril on the Prevention of Post-operative Nausea and Vomiting in Pediatric Patients Undergoing Surgery With General Anesthesia
Status: Enrolling
Updated:  2/26/2018
Clinical Research Facility
mi
from
Atlanta, GA
A Study of Kytril (Granisetron) in the Prevention of Post-Operative Nausea and Vomiting (PONV) in Pediatric Subjects Undergoing Tonsillectomy or Adenotonsillectomy
A Randomized, Double-blind Study of 2 Dose Levels of Kytril on the Prevention of Post-operative Nausea and Vomiting in Pediatric Patients Undergoing Surgery With General Anesthesia
Status: Enrolling
Updated: 2/26/2018
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Study of Kytril (Granisetron) in the Prevention of Post-Operative Nausea and Vomiting (PONV) in Pediatric Subjects Undergoing Tonsillectomy or Adenotonsillectomy
A Randomized, Double-blind Study of 2 Dose Levels of Kytril on the Prevention of Post-operative Nausea and Vomiting in Pediatric Patients Undergoing Surgery With General Anesthesia
Status: Enrolling
Updated:  2/26/2018
Clinical Research Facility
mi
from
Indianapolis, IN
A Study of Kytril (Granisetron) in the Prevention of Post-Operative Nausea and Vomiting (PONV) in Pediatric Subjects Undergoing Tonsillectomy or Adenotonsillectomy
A Randomized, Double-blind Study of 2 Dose Levels of Kytril on the Prevention of Post-operative Nausea and Vomiting in Pediatric Patients Undergoing Surgery With General Anesthesia
Status: Enrolling
Updated: 2/26/2018
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Study of Kytril (Granisetron) in the Prevention of Post-Operative Nausea and Vomiting (PONV) in Pediatric Subjects Undergoing Tonsillectomy or Adenotonsillectomy
A Randomized, Double-blind Study of 2 Dose Levels of Kytril on the Prevention of Post-operative Nausea and Vomiting in Pediatric Patients Undergoing Surgery With General Anesthesia
Status: Enrolling
Updated:  2/26/2018
Clinical Research Facility
mi
from
Baltimore, MD
A Study of Kytril (Granisetron) in the Prevention of Post-Operative Nausea and Vomiting (PONV) in Pediatric Subjects Undergoing Tonsillectomy or Adenotonsillectomy
A Randomized, Double-blind Study of 2 Dose Levels of Kytril on the Prevention of Post-operative Nausea and Vomiting in Pediatric Patients Undergoing Surgery With General Anesthesia
Status: Enrolling
Updated: 2/26/2018
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Study of Kytril (Granisetron) in the Prevention of Post-Operative Nausea and Vomiting (PONV) in Pediatric Subjects Undergoing Tonsillectomy or Adenotonsillectomy
A Randomized, Double-blind Study of 2 Dose Levels of Kytril on the Prevention of Post-operative Nausea and Vomiting in Pediatric Patients Undergoing Surgery With General Anesthesia
Status: Enrolling
Updated:  2/26/2018
Clinical Research Facility
mi
from
Boston, MA
A Study of Kytril (Granisetron) in the Prevention of Post-Operative Nausea and Vomiting (PONV) in Pediatric Subjects Undergoing Tonsillectomy or Adenotonsillectomy
A Randomized, Double-blind Study of 2 Dose Levels of Kytril on the Prevention of Post-operative Nausea and Vomiting in Pediatric Patients Undergoing Surgery With General Anesthesia
Status: Enrolling
Updated: 2/26/2018
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
A Study of Kytril (Granisetron) in the Prevention of Post-Operative Nausea and Vomiting (PONV) in Pediatric Subjects Undergoing Tonsillectomy or Adenotonsillectomy
A Randomized, Double-blind Study of 2 Dose Levels of Kytril on the Prevention of Post-operative Nausea and Vomiting in Pediatric Patients Undergoing Surgery With General Anesthesia
Status: Enrolling
Updated:  2/26/2018
Clinical Research Facility
mi
from
Pittsburgh, PA
A Study of Kytril (Granisetron) in the Prevention of Post-Operative Nausea and Vomiting (PONV) in Pediatric Subjects Undergoing Tonsillectomy or Adenotonsillectomy
A Randomized, Double-blind Study of 2 Dose Levels of Kytril on the Prevention of Post-operative Nausea and Vomiting in Pediatric Patients Undergoing Surgery With General Anesthesia
Status: Enrolling
Updated: 2/26/2018
Clinical Research Facility
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
A Study of Kytril (Granisetron) in the Prevention of Post-Operative Nausea and Vomiting (PONV) in Pediatric Subjects Undergoing Tonsillectomy or Adenotonsillectomy
A Randomized, Double-blind Study of 2 Dose Levels of Kytril on the Prevention of Post-operative Nausea and Vomiting in Pediatric Patients Undergoing Surgery With General Anesthesia
Status: Enrolling
Updated:  2/26/2018
Clinical Research Facility
mi
from
Nashville, TN
A Study of Kytril (Granisetron) in the Prevention of Post-Operative Nausea and Vomiting (PONV) in Pediatric Subjects Undergoing Tonsillectomy or Adenotonsillectomy
A Randomized, Double-blind Study of 2 Dose Levels of Kytril on the Prevention of Post-operative Nausea and Vomiting in Pediatric Patients Undergoing Surgery With General Anesthesia
Status: Enrolling
Updated: 2/26/2018
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
A Study of Kytril (Granisetron) in the Prevention of Post-Operative Nausea and Vomiting (PONV) in Pediatric Subjects Undergoing Tonsillectomy or Adenotonsillectomy
A Randomized, Double-blind Study of 2 Dose Levels of Kytril on the Prevention of Post-operative Nausea and Vomiting in Pediatric Patients Undergoing Surgery With General Anesthesia
Status: Enrolling
Updated:  2/26/2018
Clinical Research Facility
mi
from
Dallas, TX
A Study of Kytril (Granisetron) in the Prevention of Post-Operative Nausea and Vomiting (PONV) in Pediatric Subjects Undergoing Tonsillectomy or Adenotonsillectomy
A Randomized, Double-blind Study of 2 Dose Levels of Kytril on the Prevention of Post-operative Nausea and Vomiting in Pediatric Patients Undergoing Surgery With General Anesthesia
Status: Enrolling
Updated: 2/26/2018
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Brain Indices of Risk for Posttraumatic Stress Disorder (PTSD) After Mild Traumatic Brain Injury (mTBI)
Brain Indices of Risk for Posttraumatic Stress Disorder After Mild Traumatic Brain Injury
Status: Enrolling
Updated:  2/27/2018
Fort Belvoir Community Hospital
mi
from
Fort Belvoir, VA
Brain Indices of Risk for Posttraumatic Stress Disorder (PTSD) After Mild Traumatic Brain Injury (mTBI)
Brain Indices of Risk for Posttraumatic Stress Disorder After Mild Traumatic Brain Injury
Status: Enrolling
Updated: 2/27/2018
Fort Belvoir Community Hospital
mi
from
Fort Belvoir, VA
Click here to add this to my saved trials
Brain Indices of Risk for Posttraumatic Stress Disorder (PTSD) After Mild Traumatic Brain Injury (mTBI)
Brain Indices of Risk for Posttraumatic Stress Disorder After Mild Traumatic Brain Injury
Status: Enrolling
Updated:  2/27/2018
Walter Reed National Military Medical Center
mi
from
Bethesda, MD
Brain Indices of Risk for Posttraumatic Stress Disorder (PTSD) After Mild Traumatic Brain Injury (mTBI)
Brain Indices of Risk for Posttraumatic Stress Disorder After Mild Traumatic Brain Injury
Status: Enrolling
Updated: 2/27/2018
Walter Reed National Military Medical Center
mi
from
Bethesda, MD
Click here to add this to my saved trials
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated:  2/27/2018
University of California at Los Angeles
mi
from
Los Angeles, CA
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated: 2/27/2018
University of California at Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated:  2/27/2018
University of California-Davis
mi
from
Sacramento, CA
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated: 2/27/2018
University of California-Davis
mi
from
Sacramento, CA
Click here to add this to my saved trials
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated:  2/27/2018
University of Florida
mi
from
Gainesville, FL
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated: 2/27/2018
University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated:  2/27/2018
Joseph M. Still Research Foundation, Inc.
mi
from
Augusta, GA
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated: 2/27/2018
Joseph M. Still Research Foundation, Inc.
mi
from
Augusta, GA
Click here to add this to my saved trials
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated:  2/27/2018
Eastern Idaho Regional Medical Center
mi
from
Idaho Falls, ID
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated: 2/27/2018
Eastern Idaho Regional Medical Center
mi
from
Idaho Falls, ID
Click here to add this to my saved trials
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated:  2/27/2018
Northwestern University
mi
from
Chicago, IL
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated: 2/27/2018
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated:  2/27/2018
Methodist Hospital, Indiana University Health Physicians
mi
from
Indianapolis, IN
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated: 2/27/2018
Methodist Hospital, Indiana University Health Physicians
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated:  2/27/2018
Kentucky Lung Clinic
mi
from
Hazard, KY
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated: 2/27/2018
Kentucky Lung Clinic
mi
from
Hazard, KY
Click here to add this to my saved trials
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated:  2/27/2018
University of Maryland Medical Center
mi
from
Baltimore, MD
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated: 2/27/2018
University of Maryland Medical Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated:  2/27/2018
Massachusetts General Hospital
mi
from
Boston, MA
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated: 2/27/2018
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated:  2/27/2018
Brigham and Women's Hosp
mi
from
Boston, MA
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated: 2/27/2018
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated:  2/27/2018
Hennepin County Medical Center
mi
from
Minneapolis, MN
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated: 2/27/2018
Hennepin County Medical Center
mi
from
Minneapolis, MN
Click here to add this to my saved trials
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated:  2/27/2018
The Mayo Clinic
mi
from
Rochester, MN
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated: 2/27/2018
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated:  2/27/2018
Sunrise Hospital/eStudySite
mi
from
Las Vegas, NV
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated: 2/27/2018
Sunrise Hospital/eStudySite
mi
from
Las Vegas, NV
Click here to add this to my saved trials
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated:  2/27/2018
Englewood Hospital and Medical Center
mi
from
Englewood, NJ
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated: 2/27/2018
Englewood Hospital and Medical Center
mi
from
Englewood, NJ
Click here to add this to my saved trials
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated:  2/27/2018
Rutgers Robert Wood Johnson Medical Center
mi
from
New Brunswick, NJ
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated: 2/27/2018
Rutgers Robert Wood Johnson Medical Center
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated:  2/27/2018
Montefiore Medical Center
mi
from
Bronx, NY
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated: 2/27/2018
Montefiore Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials